comparemela.com

Latest Breaking News On - Cormorant asset - Page 3 : comparemela.com

New Year's Insider Buying Focuses on Biotechs

As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.

Houston
Texas
United-states
Phillip-frost
Joshua-brum
Gentex-corp
A-voxx-international-insider
Opko-health-inc
Walgreens-boots-alliance
Voxx-international-corp
Eyepoint-pharmaceuticals-inc
Dyne-therapeutics-inc

Huge Warren Buffett Purchase Highlights Hot Insider Buying

Huge Warren Buffett Purchase Highlights Hot Insider Buying
247wallst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 247wallst.com Daily Mail and Mail on Sunday newspapers.

United-states
Alaska
America
Warren-buffett
Dow-jones
Madrigal-pharmaceuticals
Berkshire-hathaway
Disney
Eyepoint-pharmaceuticals
Occidental-petroleum
Lovesac-co
Madrigal-pharmaceuticals-inc

What Has Insiders Eyeing This Biotech Stock

What Has Insiders Eyeing This Biotech Stock
247wallst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 247wallst.com Daily Mail and Mail on Sunday newspapers.

Indiana
United-states
Dwayne-weaver
Bristol-myers-squibb
Petco-health
Citi-trends-inc
Erasca-inc
Akero-therapeutics-inc
Pulse-biosciences-inc
Consolidated-edison
Nasdaq
Flickr

SUPIRA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION AS THE COMPANY CLOSED $40M IN SERIES D FINANCING

SUPIRA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION AS THE COMPANY CLOSED $40M IN SERIES D FINANCING
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Charlene-herndon
Nitin-salunke
Amr-salahieh
Bihua-chen
Drug-administration
Supira-medical-inc
Capital-partnership
Supira-medical
Supira-system
Cormorant-asset-management
Unorthodox-ventures
Managing-member

Biotech Startup Triveni Unveils $92M to Address Barrier to Treating Inflammation

Available atopic dermatitis drugs work by blocking inflammation, but Triveni Bio is developing an antibody that addresses a root cause of the chronic condition. The startup is out of stealth to advance its lead program and a pipeline of other inflammation and immunology drugs.

Boston
Massachusetts
United-states
Waltham
Alexandria
Al-iskandariyah
Egypt
Vishal-patel
Tillman-gerngross
Jennifer-dovey
Triveni-bio
Pharma-adbry

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.